{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:20:59Z","timestamp":1782980459685,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40266-021-00866-2","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T06:18:32Z","timestamp":1623219512000},"page":"545-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity"],"prefix":"10.1007","volume":"38","author":[{"given":"Mukund","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"866_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00296-017-3777-3","volume":"37","author":"CA Janssen","year":"2017","unstructured":"Janssen CA, Jansen TLTA, Oude Voshaar MAH, Vonkeman HE, van de Laar MAFJ. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients. Rheumatol Int. 2017;37:1435\u201340.","journal-title":"Rheumatol Int"},{"key":"866_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"E Roddy","year":"2010","unstructured":"Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12:223.","journal-title":"Arthritis Res Ther"},{"key":"866_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/00325481.2016.1114878","volume":"128","author":"PP Doghramji","year":"2016","unstructured":"Doghramji PP, Fermer S, Wood R, Morlock R, Baumgartner S. Management of gout in the real world: current practice versus guideline recommendations. Postgrad Med. 2016;128:106\u201314.","journal-title":"Postgrad Med"},{"key":"866_CR4","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/annrheumdis-2013-204647","volume":"73","author":"E Smith","year":"2014","unstructured":"Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:1470.","journal-title":"Ann Rheum Dis"},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2013.04.003","volume":"75","author":"A Wertheimer","year":"2013","unstructured":"Wertheimer A, Morlock R, Becker MA. A revised estimate of the burden of illness of gout. Curr Ther Res. 2013;75:1\u20134.","journal-title":"Curr Ther Res"},{"key":"866_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2018.1532904","volume":"22","author":"NM Flores","year":"2019","unstructured":"Flores NM, Nuevo J, Klein AB, Baumgartner S, Morlock R. The economic burden of uncontrolled gout: how controlling gout reduces cost. J Med Econ. 2019:22:1\u20136.","journal-title":"J Med Econ."},{"key":"866_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acr.22469","volume":"67","author":"SP Juraschek","year":"2015","unstructured":"Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Gout, urate-lowering therapy, and uric acid levels among adults in the United States. Arthritis Care Res. 2015;67:588\u201392.","journal-title":"Arthritis Care Res"},{"key":"866_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007\u20132016. Arthritis Rheumatol (Hoboken, NJ). 2019;71:991\u20139.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"866_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01.rhu.0000147049.12220.32","volume":"10","author":"AA Riedel","year":"2004","unstructured":"Riedel AA, Nelson M, Wallace K, Joseph-Ridge N, Cleary M, Fam AG. Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting. J Clin Rheumatol. 2004;10:308\u201314.","journal-title":"J Clin Rheumatol"},{"key":"866_CR10","doi-asserted-by":"publisher","unstructured":"Helget LN, England BR, Roul P, Sayles H, Petro AD, Michaud K, et al. The incidence, prevalence, and burden of gout in the Veterans Health Administration. Arthritis Care Res. 2020. https:\/\/doi.org\/10.1002\/acr.24339.","DOI":"10.1002\/acr.24339"},{"key":"866_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis. 2008;67:960\u20136.","journal-title":"Ann Rheum Dis"},{"key":"866_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40520-013-0031-z","volume":"25","author":"F Bolzetta","year":"2013","unstructured":"Bolzetta F, Veronese N, Manzato E, Sergi G. Chronic gout in the elderly. Aging Clin Exp Res. 2013;25:129\u201337.","journal-title":"Aging Clin Exp Res"},{"key":"866_CR13","first-page":"S451","volume":"11","author":"AC Cannella","year":"2005","unstructured":"Cannella AC, Mikuls TR. Understanding treatments for gout. Am J Manag Care. 2005;11:S451\u20138.","journal-title":"Am J Manag Care"},{"key":"866_CR14","doi-asserted-by":"publisher","first-page":"k3951","DOI":"10.1136\/bmj.k3951","volume":"363","author":"TJ Major","year":"2018","unstructured":"Major TJ, Topless RK, Dalbeth N, Merriman TR. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ. 2018;363:k3951.","journal-title":"BMJ"},{"key":"866_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa035700","volume":"350","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093\u2013103.","journal-title":"N Engl J Med"},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","volume":"363","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363:1277\u201381.","journal-title":"Lancet"},{"key":"866_CR17","first-page":"164","volume":"14","author":"EQ Wu","year":"2008","unstructured":"Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm. 2008;14:164\u201375.","journal-title":"J Manag Care Pharm"},{"key":"866_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3899\/jrheum.151419","volume":"43","author":"JA Singh","year":"2016","unstructured":"Singh JA, Yu S. Time trends, predictors, and outcome of emergency department use for gout: a nationwide US study. J Rheumatol. 2016;43:1581\u20138.","journal-title":"J Rheumatol"},{"key":"866_CR19","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/acr.23544","volume":"70","author":"D Bulbin","year":"2018","unstructured":"Bulbin D, Denio AE, Berger A, Brown J, Maynard C, Sharma T, et al. Improved gout outcomes in primary care using a novel disease management program: a pilot study. Arthritis Care Res (Hoboken). 2018;70:1679\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"866_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13075-016-0936-y","volume":"18","author":"JA Singh","year":"2016","unstructured":"Singh JA, Yu S. Gout-related inpatient utilization: a study of predictors of outcomes and time trends. Arthritis Res Ther. 2016;18:57.","journal-title":"Arthritis Res Ther"},{"key":"866_CR21","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2016.3517","volume":"315","author":"SY Lim","year":"2016","unstructured":"Lim SY, Lu N, Oza A, Fisher M, Rai SK, Menendez ME, et al. Trends in Gout and Rheumatoid Arthritis Hospitalizations in the United States, 1993\u20132011. JAMA. 2016;315:2345\u20137.","journal-title":"JAMA"},{"key":"866_CR22","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/acr.22856","volume":"68","author":"G Han","year":"2016","unstructured":"Han G, Michaud K, Yu F, Watanabe-Galloway S, Mikuls TR. Increasing public health burden of arthritis and other rheumatic conditions and comorbidity: results from a Statewide Health Surveillance System, 2007\u20132012. Arthritis Care Res. 2016;68:1417\u201327.","journal-title":"Arthritis Care Res"},{"key":"866_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.clinthera.2012.01.020","volume":"34","author":"H Park","year":"2012","unstructured":"Park H, Rascati KL, Prasla K, McBayne T. Evaluation of health care costs and utilization patterns for patients with gout. Clin Ther. 2012;34:640\u201352.","journal-title":"Clin Ther"},{"key":"866_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semarthrit.2015.02.004","volume":"45","author":"SK Rai","year":"2015","unstructured":"Rai SK, Burns LC, De Vera MA, Haji A, Giustini D, Choi HK. The economic burden of gout: a systematic review. Semin Arthritis Rheum. 2015;45:75\u201380.","journal-title":"Semin Arthritis Rheum"},{"key":"866_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jbspin.2015.12.003","volume":"84","author":"HJ Janssens","year":"2017","unstructured":"Janssens HJ, Arts PG, Schalk BW, Biermans MC. Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: a primary care retrospective cohort study. Joint Bone Spine. 2017;84:59\u201364.","journal-title":"Joint Bone Spine"},{"key":"866_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999. Ann Rheum Dis. 2005;64:267\u201372.","journal-title":"Ann Rheum Dis"},{"key":"866_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1071\/HC17046","volume":"10","author":"T Stokes","year":"2018","unstructured":"Stokes T, Azam M, Noble FD. Multimorbidity in M\u0101ori and Pacific patients: cross-sectional study in a Dunedin general practice. J Prim Health Care. 2018;10:39\u201343.","journal-title":"J Prim Health Care"},{"key":"866_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15:123.","journal-title":"BMC Med"},{"key":"866_CR29","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/art.41008","volume":"71","author":"A Vargas-Santos","year":"2019","unstructured":"Vargas-Santos A, Neogi T, da Rocha C-PG, Kapetanovic MC, Turkiewicz A. Cause-specific mortality in gout: novel findings of elevated risk of non-cardiovascular-related deaths. Arthritis Rheumatol (Hoboken, NJ). 2019;71:1935\u201342.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"866_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.semarthrit.2020.06.001","volume":"50","author":"S Stewart","year":"2020","unstructured":"Stewart S, Guillen AG, Taylor WJ, Gaffo A, Slark J, Gott M, et al. The experience of a gout flare: a meta-synthesis of qualitative studies. Semin Arthritis Rheum. 2020;50:805\u201311.","journal-title":"Semin Arthritis Rheum"},{"key":"866_CR31","doi-asserted-by":"publisher","unstructured":"Garcia-Guillen A, Stewart S, Su I, Taylor WJ, Gaffo AL, Gott M, et al. Gout flare severity from the patient perspective: a qualitative interview study. Arthritis Care Res (Hoboken). 2020. https:\/\/doi.org\/10.1002\/acr.24475.","DOI":"10.1002\/acr.24475"},{"key":"866_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","volume":"26","author":"T Bardin","year":"2014","unstructured":"Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26:186\u201391.","journal-title":"Curr Opin Rheumatol"},{"key":"866_CR33","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/annrheumdis-2014-205304","volume":"73","author":"N Dalbeth","year":"2014","unstructured":"Dalbeth N, Stamp L. Hyperuricaemia and gout: time for a new staging system? Ann Rheum Dis. 2014;73:1598.","journal-title":"Ann Rheum Dis"},{"key":"866_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken). 2020;72:744\u201360.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"866_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med. 2012;125:679-687.e1.","journal-title":"Am J Med"},{"key":"866_CR36","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74:1789\u201398.","journal-title":"Ann Rheum Dis"},{"key":"866_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/art.38917","volume":"67","author":"HK Choi","year":"2015","unstructured":"Choi HK, Niu J, Neogi T, Chen CA, Chaisson C, Hunter D, et al. Nocturnal risk of gout attacks. Arthritis Rheumatol (Hoboken, NJ). 2015;67:555\u201362.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"866_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/11592750-000000000-00000","volume":"28","author":"LK Stamp","year":"2011","unstructured":"Stamp LK, Jordan S. The challenges of gout management in the elderly. Drugs Aging. 2011;28:591\u2013603.","journal-title":"Drugs Aging"},{"key":"866_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-007-0421-7","volume":"28","author":"F De Leonardis","year":"2007","unstructured":"De Leonardis F, Govoni M, Colina M, Bruschi M, Trotta F. Elderly-onset gout: a review. Rheumatol Int. 2007;28:1\u20136.","journal-title":"Rheumatol Int"},{"key":"866_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0749-0690(18)30750-X","volume":"4","author":"AJ Reginato","year":"1988","unstructured":"Reginato AJ, Schumacher HR Jr. Crystal-associated arthropathies. Clin Geriatr Med. 1988;4:295\u2013322.","journal-title":"Clin Geriatr Med"},{"key":"866_CR41","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.297.13.1478","volume":"297","author":"ME Margaretten","year":"2007","unstructured":"Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA. 2007;297:1478\u201388.","journal-title":"JAMA"},{"key":"866_CR42","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s40266-017-0512-4","volume":"34","author":"A Abhishek","year":"2017","unstructured":"Abhishek A. Managing gout flares in the elderly: practical considerations. Drugs Aging. 2017;34:873\u201380.","journal-title":"Drugs Aging"},{"key":"866_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00391-017-1198-2","volume":"51","author":"S Schlee","year":"2018","unstructured":"Schlee S, Bollheimer LC, Bertsch T, Sieber CC, H\u00e4rle P. Crystal arthritides\u2014gout and calcium pyrophosphate arthritis: part 2: clinical features, diagnosis and differential diagnostics. Z Gerontol Geriatr. 2018;51:579\u201384.","journal-title":"Z Gerontol Geriatr"},{"key":"866_CR44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","volume":"131","author":"E Pascual","year":"1999","unstructured":"Pascual E, Batlle-Gualda E, Mart\u00ednez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med. 1999;131:756\u20139.","journal-title":"Ann Intern Med"},{"key":"866_CR45","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388:2039\u201352.","journal-title":"Lancet"},{"key":"866_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00005792-198809000-00004","volume":"67","author":"GV Lawry 2nd","year":"1988","unstructured":"Lawry GV 2nd, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine (Baltimore). 1988;67:335\u201343.","journal-title":"Medicine (Baltimore)"},{"key":"866_CR47","first-page":"1566","volume":"34","author":"D Petersel","year":"2007","unstructured":"Petersel D, Schlesinger N. Treatment of acute gout in hospitalized patients. J Rheumatol. 2007;34:1566\u20138.","journal-title":"J Rheumatol"},{"key":"866_CR48","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.56.11.696a","volume":"56","author":"JA Logan","year":"1997","unstructured":"Logan JA, Morrison E, McGill PE. Serum uric acid in acute gout. Ann Rheum Dis. 1997;56:696\u20137.","journal-title":"Ann Rheum Dis"},{"key":"866_CR49","first-page":"S443","volume":"11","author":"N Schlesinger","year":"2005","unstructured":"Schlesinger N. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care. 2005;11:S443\u20138.","journal-title":"Am J Manag Care"},{"key":"866_CR50","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3899\/jrheum.080938","volume":"36","author":"N Schlesinger","year":"2009","unstructured":"Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol. 2009;36:1287\u20139.","journal-title":"J Rheumatol"},{"key":"866_CR51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00256-014-2005-4","volume":"44","author":"N Upadhyay","year":"2015","unstructured":"Upadhyay N, Saifuddin A. The radiographic and MRI features of gout referred as suspected soft tissue sarcoma: a review of the literature and findings from 27 cases. Skelet Radiol. 2015;44:467\u201376.","journal-title":"Skelet Radiol"},{"key":"866_CR52","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.rdc.2016.07.005","volume":"42","author":"P Omoumi","year":"2016","unstructured":"Omoumi P, Zufferey P, Malghem J, So A. Imaging in gout and other crystal-related arthropathies. Rheum Dis Clin N Am. 2016;42:621\u201344.","journal-title":"Rheum Dis Clin N Am"},{"key":"866_CR53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11926-010-0156-4","volume":"13","author":"RG Thiele","year":"2011","unstructured":"Thiele RG. Role of ultrasound and other advanced imaging in the diagnosis and management of gout. Curr Rheumatol Rep. 2011;13:146\u201353.","journal-title":"Curr Rheumatol Rep"},{"key":"866_CR54","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1148\/radiol.11102485","volume":"261","author":"KN Glazebrook","year":"2011","unstructured":"Glazebrook KN, Guimar\u00e3es LS, Murthy NS, Black DF, Bongartz T, Manek NJ, et al. Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation. Radiology. 2011;261:516\u201324.","journal-title":"Radiology"},{"key":"866_CR55","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2214\/AJR.09.2428","volume":"194","author":"S Nicolaou","year":"2010","unstructured":"Nicolaou S, Yong-Hing CJ, Galea-Soler S, Hou DJ, Louis L, Munk P. Dual-energy CT as a potential new diagnostic tool in the management of gout in the acute setting. AJR Am J Roentgenol. 2010;194:1072\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"866_CR56","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3899\/jrheum.170203","volume":"44","author":"M Carroll","year":"2017","unstructured":"Carroll M, Dalbeth N, Allen B, Stewart S, House T, Boocock M, et al. Ultrasound characteristics of the achilles tendon in tophaceous gout: a comparison with age- and sex-matched controls. J Rheumatol. 2017;44:1487\u201392.","journal-title":"J Rheumatol"},{"key":"866_CR57","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/rheumatology\/keu378","volume":"54","author":"LBE Kienhorst","year":"2015","unstructured":"Kienhorst LBE, Janssens HJEM, Fransen J, Janssen M. The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study. Rheumatology (Oxford). 2015;54:609\u201314.","journal-title":"Rheumatology (Oxford)"},{"key":"866_CR58","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/archinternmed.2010.196","volume":"170","author":"HJEM Janssens","year":"2010","unstructured":"Janssens HJEM, Fransen J, van de Lisdonk EH, van Riel PLCM, van Weel C, Janssen M. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med. 2010;170:1120\u20136.","journal-title":"Arch Intern Med"},{"key":"866_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29.","journal-title":"Ann Rheum Dis"},{"key":"866_CR60","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi T. Clinical practice. Gout. N Engl J Med. 2011;364:443\u201352.","journal-title":"N Engl J Med"},{"key":"866_CR61","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62:1060\u20138.","journal-title":"Arthritis Rheum"},{"key":"866_CR62","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","volume":"63","author":"RA Terkeltaub","year":"2011","unstructured":"Terkeltaub RA, Furst DE, DiGiacinto JL, Kook KA, Davis MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63:2226\u201337.","journal-title":"Arthritis Rheum"},{"key":"866_CR63","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","volume":"70","author":"A Vargas-Santos","year":"2017","unstructured":"Vargas-Santos A, Neogi T. Management of gout and hyperuricemia in CKD. Am J Kidney Dis. 2017;70:422\u201339.","journal-title":"Am J Kidney Dis"},{"key":"866_CR64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3899\/jrheum.170137","volume":"45","author":"CA Billy","year":"2018","unstructured":"Billy CA, Lim RT, Ruospo M, Palmer SC, Strippoli GFM. Corticosteroid or nonsteroidal antiinflammatory drugs for the treatment of acute gout: a systematic review of randomized controlled trials. J Rheumatol. 2018;45:128\u201336.","journal-title":"J Rheumatol"},{"key":"866_CR65","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","volume":"371","author":"HJ Janssens","year":"2008","unstructured":"Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;371:1854\u201360.","journal-title":"Lancet"},{"key":"866_CR66","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","volume":"49","author":"CY Man","year":"2007","unstructured":"Man CY, Cheung IT, Cameron PA, Rainer TH. Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med. 2007;49:670\u20137.","journal-title":"Ann Emerg Med"},{"key":"866_CR67","doi-asserted-by":"crossref","unstructured":"Wechalekar MD, Vinik O, Schlesinger N, Buchbinder R. Intra-articular glucocorticoids for acute gout. Cochrane Database Syst Rev. 2013;(4):CD009920.","DOI":"10.1002\/14651858.CD009920.pub2"},{"key":"866_CR68","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken). 2012;64:1447\u201361.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"13\u20138","key":"866_CR69","first-page":"20","volume":"63","author":"H Singh","year":"2008","unstructured":"Singh H, Torralba KD. Therapeutic challenges in the management of gout in the elderly. Geriatrics. 2008;63(13\u20138):20.","journal-title":"Geriatrics"},{"key":"866_CR70","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbspin.2012.09.009","volume":"80","author":"D Daoussis","year":"2013","unstructured":"Daoussis D, Antonopoulos I, Yiannopoulos G, Andonopoulos AP. ACTH as first line treatment for acute gout in 181 hospitalized patients. Jt Bone Spine. 2013;80:291\u20134.","journal-title":"Jt Bone Spine"},{"key":"866_CR71","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00296-020-04659-5","volume":"40","author":"D Daoussis","year":"2020","unstructured":"Daoussis D, Bogdanos DP, Dimitroulas T, Sakkas L, Andonopoulos AP. Adrenocorticotropic hormone: an effective \u201cnatural\u201d biologic therapy for acute gout? Rheumatol Int. 2020;40:1941\u20137.","journal-title":"Rheumatol Int"},{"key":"866_CR72","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.semarthrit.2010.03.001","volume":"40","author":"K Chen","year":"2010","unstructured":"Chen K, Fields T, Mancuso CA, Bass AR, Vasanth L. Anakinra\u2019s efficacy is variable in refractory gout: report of ten cases. Semin Arthritis Rheum. 2010;40:210\u20134.","journal-title":"Semin Arthritis Rheum"},{"key":"866_CR73","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 2007;9:R28.","journal-title":"Arthritis Res Ther"},{"key":"866_CR74","doi-asserted-by":"publisher","unstructured":"Saag KG, Khanna PP, Keenan RT, Ohlman S, Osterling Koskinen L, Sparve E, et al. A randomized, phase 2 study evaluating the efficacy and safety of anakinra in the treatment of gout flares. Arthritis Rheumatol. 2021. https:\/\/doi.org\/10.1002\/art.41699.","DOI":"10.1002\/art.41699"},{"key":"866_CR75","first-page":"331","volume":"29","author":"N Schlesinger","year":"2002","unstructured":"Schlesinger N, Detry MA, Holland BK, Baker DG, Beutler AM, Rull M, et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol. 2002;29:331.","journal-title":"J Rheumatol"},{"key":"866_CR76","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/acr.23928","volume":"72","author":"DS Dalal","year":"2020","unstructured":"Dalal DS, Mbuyi N, Shah I, Reinert S, Hilliard R, Reginato A. Prescription opioid use among patients with acute gout discharged from the emergency department. Arthritis Care Res (Hoboken). 2020;72:1163\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"866_CR77","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3899\/jrheum.191370","volume":"48","author":"JA Singh","year":"2021","unstructured":"Singh JA, Cleveland JD. Time trends in opioid use disorder hospitalizations in gout, rheumatoid arthritis, fibromyalgia, osteoarthritis, and low back pain. J Rheumatol. 2021;48:775\u201384.","journal-title":"J Rheumatol"},{"key":"866_CR78","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. The British Society for rheumatology guideline for the management of gout. Rheumatology (Oxford). 2017;56:e1\u201320.","journal-title":"Rheumatology (Oxford)"},{"key":"866_CR79","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/art.10511","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47:356\u201360.","journal-title":"Arthritis Rheum"},{"key":"866_CR80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"A Shoji","year":"2004","unstructured":"Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51:321\u20135.","journal-title":"Arthritis Rheum"},{"key":"866_CR81","first-page":"577","volume":"28","author":"J Li-Yu","year":"2001","unstructured":"Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol. 2001;28:577\u201380.","journal-title":"J Rheumatol"},{"key":"866_CR82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1060028016679848","volume":"51","author":"JC Hughes","year":"2017","unstructured":"Hughes JC, Wallace JL, Bryant CL, Salvig BE, Fourakre TN, Stone WJ. Monitoring of urate-lowering therapy among us veterans following the 2012 American college of rheumatology guidelines for management of gout. Ann Pharmacother. 2017;51:301\u20136.","journal-title":"Ann Pharmacother"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00866-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-021-00866-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00866-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T19:27:50Z","timestamp":1675452470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-021-00866-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s40266-021-00866-2","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"18 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"TRM has received prior research funding and has served as a consultant for Horizon Therapeutics. MK and NM have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"All authors were involved in the literature search, the initial drafting of the manuscript, and the revision and approval of the final manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}